X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-02 | XGN | Exagen Inc. | Black Jeffrey G. | CFO | S - Sale | $9.79 | -20,466 | 269,026 | -7% | -$200,362 | ||||||
2025-09-02 | FTRE | Fortrea Holdings Inc. | Russell Erin L | Dir | P - Purchase | $10.15 | +9,854 | 9,854 | New | +$100,018 | ||||||
2025-09-02 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $23.93 | -1,339 | 328,377 | 0% | -$32,042 | ||||||
2025-09-02 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale | $65.84 | -100 | 11,183 | -1% | -$6,584 | ||||||
2025-09-03 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $22.03 | -1,063 | 957,085 | 0% | -$23,414 | ||||||
2025-09-03 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $22.03 | -1,128 | 584,937 | 0% | -$24,846 | ||||||
2025-08-29 | BDSX | Biodesix Inc | Schuler Jack W | Dir, 10% | P - Purchase | $0.43 | +3,488,372 | 39,406,546 | +10% | +$1,500,000 | ||||||
2025-09-02 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $3.49 | -1,458 | 176,940 | -1% | -$5,088 | ||||||
2025-08-28 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $166.99 | -2,750 | 6,015 | -31% | -$459,223 | ||||||
2025-08-29 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $3.49 | -10,542 | 178,398 | -6% | -$36,792 | ||||||
2025-08-27 | RDNT | Radnet, Inc. | Hames Norman R | Pres, COO-West Operations | S - Sale | $71.10 | -5,000 | 19,889 | -20% | -$355,500 | ||||||
2025-08-27 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $22.02 | -12,677 | 141,116 | -8% | -$279,135 | ||||||
2025-08-27 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $21.69 | -18,007 | 153,793 | -10% | -$390,572 | ||||||
2025-08-27 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $21.48 | -1,199 | 586,065 | 0% | -$25,760 | ||||||
2025-08-27 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $21.48 | -943 | 958,148 | 0% | -$20,260 | ||||||
2025-08-25 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $21.50 | -696 | 587,264 | 0% | -$14,965 | ||||||
2025-08-25 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $21.50 | -548 | 959,091 | 0% | -$11,783 | ||||||
2025-08-21 | DGX | Quest Diagnostics Inc | Plewman Patrick | SVP for Diagnostic Services | S - Sale | $185.00 | -1,975 | 15,269 | -11% | -$365,375 | ||||||
2025-08-21 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale | $61.76 | -2,000 | 18,500 | -10% | -$123,510 | ||||||
| D | 2025-08-19 | DGX | Quest Diagnostics Inc | Plewman Patrick | SVP for Diagnostic Services | S - Sale+OE | $183.00 | -4,532 | 17,244 | -21% | -$829,356 | |||||
2025-08-19 | RDNT | Radnet, Inc. | Wesdorp Cornelis | Pres, CEO, Digital Health | S - Sale | $66.98 | -1,500 | 54,495 | -3% | -$100,470 | ||||||
2025-08-19 | RDNT | Radnet, Inc. | Jayanathan Ranjan | CIO | S - Sale | $67.50 | -65,598 | 138,198 | -32% | -$4,427,865 | ||||||
2025-08-19 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $59.02 | -116 | 7,458 | -2% | -$6,846 | ||||||
2025-08-19 | GH | Guardant Health, Inc. | Potter Myrtle S | Dir | S - Sale | $59.02 | -26 | 18,239 | 0% | -$1,535 | ||||||
2025-08-20 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $2.22 | -6,000 | 102,577 | -6% | -$13,320 | ||||||
| D | 2025-08-19 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $8.01 | -4,886 | 57,600 | -8% | -$39,137 | |||||
| D | 2025-08-19 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $8.01 | -4,886 | 54,770 | -8% | -$39,137 | |||||
2025-08-19 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $32.02 | -4,202 | 487,874 | -1% | -$134,548 | ||||||
2025-08-19 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $32.02 | -877 | 285,143 | 0% | -$28,082 | ||||||
2025-08-15 | DGX | Quest Diagnostics Inc | Plewman Patrick | SVP for Diagnostic Services | S - Sale | $180.00 | -1,975 | 17,244 | -10% | -$355,500 | ||||||
2025-08-15 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.04 | -1,339 | 329,716 | 0% | -$26,834 | ||||||
2025-08-14 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $155.46 | -875 | 123,859 | -1% | -$136,027 | ||||||
2025-08-14 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $155.46 | -678 | 152,747 | 0% | -$105,401 | ||||||
2025-08-13 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $19.50 | -43,019 | 331,055 | -12% | -$839,043 | ||||||
| D | 2025-08-13 | LH | Labcorp Holdings Inc. | Van Der Vaart Sandra D | EVP, GC | S - Sale+OE | $271.43 | -3,903 | 2,274 | -63% | -$1,059,371 | |||||
2025-08-13 | RDNT | Radnet, Inc. | Katz David Jeffrey | EVP, GC | S - Sale | $68.31 | -17,000 | 86,774 | -16% | -$1,161,270 | ||||||
| D | 2025-08-13 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $0.42 | -988 | 250,794 | 0% | -$411 | |||||
| D | 2025-08-13 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $0.42 | -3,772 | 728,824 | -1% | -$1,570 | |||||
| D | 2025-08-13 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $0.42 | -476 | 140,065 | 0% | -$198 | |||||
| D | 2025-08-13 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $0.42 | -442 | 157,878 | 0% | -$184 | |||||
| D | 2025-08-13 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $0.42 | -228 | 18,375 | -1% | -$95 | |||||
2025-08-13 | EXAS | Exact Sciences Corp | Doyle James Edward | Dir | S - Sale | $42.02 | -1,485 | 59,962 | -2% | -$62,400 | ||||||
2025-08-11 | LH | Labcorp Holdings Inc. | Schechter Adam H | Pres, CEO | S - Sale | $266.78 | -5,643 | 93,319 | -6% | -$1,505,440 | ||||||
| M | 2025-08-08 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $157.84 | -6,070 | 310,816 | -2% | -$958,059 | |||||
| M | 2025-08-08 | FTRE | Fortrea Holdings Inc. | Neupert Peter M | Dir | P - Purchase | $6.51 | +62,500 | 98,132 | +175% | +$407,150 | |||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $2.54 | -8,571 | 832,294 | -1% | -$21,770 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $2.54 | -6,460 | 188,940 | -3% | -$16,408 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $2.54 | -6,447 | 127,751 | -5% | -$16,375 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $2.54 | -5,962 | 108,577 | -5% | -$15,143 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $2.54 | -7,094 | 160,888 | -4% | -$18,019 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $2.54 | -5,800 | 290,848 | -2% | -$14,732 | ||||||
| D | 2025-08-06 | DGX | Quest Diagnostics Inc | Plewman Patrick | SVP for Diagnostic Services | S - Sale+OE | $175.00 | -5,535 | 19,219 | -22% | -$968,625 | |||||
2025-08-05 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $12.79 | -2,688 | 112,930 | -2% | -$34,381 | ||||||
2025-08-01 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $132.88 | -5,807 | 163,593 | -3% | -$771,656 | ||||||
2025-08-01 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale | $133.17 | -2,496 | 5,763 | -30% | -$332,395 | ||||||
2025-08-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $132.89 | -3,000 | 123,059 | -2% | -$398,657 | ||||||
2025-08-05 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $2.50 | -225 | 58,702 | 0% | -$563 | ||||||
| DM | 2025-07-30 | DGX | Quest Diagnostics Inc | Kuppusamy Karthik | SVP, Clinical Solutions | S - Sale+OE | $167.95 | -10,479 | 10,437 | -50% | -$1,759,931 | |||||
2025-07-30 | LH | Labcorp Holdings Inc. | Gilliland Dwight Gary | Dir | S - Sale | $264.95 | -2,000 | 6,656 | -23% | -$529,900 | ||||||
2025-07-29 | LH | Labcorp Holdings Inc. | Wilkinson Peter J | SVP, Chief Accounting Officer | S - Sale | $261.02 | -202 | 1,852 | -10% | -$52,727 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $139.81 | -6,092 | 169,400 | -3% | -$851,712 | ||||||
| M | 2025-07-28 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $138.36 | -5,064 | 65,430 | -7% | -$700,670 | |||||
2025-07-28 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $139.81 | -479 | 316,886 | 0% | -$66,968 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $139.81 | -1,718 | 2,390,852 | 0% | -$240,191 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $139.81 | -2,206 | 126,059 | -2% | -$308,417 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $139.81 | -1,710 | 151,750 | -1% | -$239,072 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $139.81 | -1,994 | 202,164 | -1% | -$278,778 | ||||||
2025-07-28 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $6.57 | -452 | 124,505 | 0% | -$2,970 | ||||||
2025-07-28 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $6.57 | -641 | 164,458 | 0% | -$4,211 | ||||||
2025-07-28 | CELC | Celcuity Inc. | Dalvey David | Dir | S - Sale | $44.07 | -109,325 | 125,000 | -47% | -$4,818,370 | ||||||
2025-07-30 | OPGN | Opgen Inc | Aei Capital Ltd | 10% | P - Purchase | $4.79 | +1,000 | 7,646,603 | 0% | +$4,790 | ||||||
2025-07-24 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $280.00 | -3,500 | 8,666 | -29% | -$980,000 | ||||||
2025-07-24 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $280.00 | -3,500 | 8,666 | -29% | -$980,000 | ||||||
| DM | 2025-07-22 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $139.94 | -2,170 | 70,494 | -3% | -$303,669 | |||||
| D | 2025-07-21 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $139.29 | -602 | 71,414 | -1% | -$83,853 | |||||
| D | 2025-07-21 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $139.29 | -1,622 | 175,492 | -1% | -$225,928 | |||||
| DM | 2025-06-18 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $169.79 | -20,372 | 204,158 | -9% | -$3,459,007 | |||||
| D | 2025-07-21 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $139.29 | -93 | 317,365 | 0% | -$12,954 | |||||
| M | 2025-05-27 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $154.22 | -1,940 | 128,265 | -1% | -$299,180 | |||||
| M | 2025-05-27 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $153.50 | -1,777 | 153,460 | -1% | -$272,770 | |||||
2025-07-16 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $149.96 | -3,070 | 317,268 | -1% | -$460,388 | ||||||
2025-07-17 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $48.20 | -116 | 7,324 | -2% | -$5,591 | ||||||
2025-07-17 | GH | Guardant Health, Inc. | Potter Myrtle S | Dir | S - Sale | $48.20 | -26 | 18,196 | 0% | -$1,253 | ||||||
2025-07-15 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $38.93 | -8,000 | 286,020 | -3% | -$311,440 | ||||||
2025-07-07 | CDNA | Caredx, Inc. | Maag Peter | Dir | S - Sale | $18.58 | -10,000 | 308,846 | -3% | -$185,831 | ||||||
2025-07-07 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $2.36 | -234 | 58,927 | 0% | -$552 | ||||||
2025-07-02 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $160.10 | -3,000 | 320,338 | -1% | -$480,309 | ||||||
2025-07-01 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $166.53 | -5,343 | 348,104 | -2% | -$889,778 | ||||||
2025-07-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $166.77 | -3,000 | 130,205 | -2% | -$500,305 | ||||||
| D | 2025-07-01 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale+OE | $167.36 | -4,299 | 8,118 | -35% | -$719,491 | |||||
2025-07-01 | GRAL | Grail, Inc. | Ding Chun R | 10% | S - Sale | $49.53 | -339,800 | 3,305,055 | -9% | -$16,830,151 | ||||||
| D | 2025-07-01 | GH | Guardant Health, Inc. | Talasaz Amirali | Co-CEO | S - Sale+OE | $50.88 | -100,000 | 1,983,665 | -5% | -$5,087,630 | |||||
2025-07-01 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $265.00 | -500 | 12,454 | -4% | -$132,500 | ||||||
2025-06-30 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $52.00 | -9,692 | 492,076 | -2% | -$503,984 | ||||||
2025-06-27 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.30 | -22,576 | 331,055 | -6% | -$458,293 | ||||||
| D | 2025-06-20 | CAI | Caris Life Sciences, Inc. | Denton John Russel | See Remarks | P - Purchase | $21.00 | +7,500 | 128,591 | +6% | +$157,500 | |||||
2025-06-20 | CAI | Caris Life Sciences, Inc. | Brille Brian J | See Remarks | P - Purchase | $21.00 | +30,000 | 662,428 | +5% | +$630,000 | ||||||
2025-06-18 | CDNA | Caredx, Inc. | Valantine Hannah | Dir | S - Sale | $19.16 | -10,570 | 38,994 | -21% | -$202,566 | ||||||
| M | 2025-05-15 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $155.26 | -54,000 | 2,392,570 | -2% | -$8,384,150 | |||||
| M | 2025-06-18 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $165.93 | -6,070 | 323,338 | -2% | -$1,007,220 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |